Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.
about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Databases for Congenital Heart Defect Public Health Studies Across the LifespanMaternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.Editorial perspectives from the founding CDC leadership of the National Birth Defects Prevention study.Antidepressant use in pregnant and postpartum womenGenome-wide association study of maternal and inherited effects on left-sided cardiac malformationsSelective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).Cardiac dysfunction and prenatal exposure to venlafaxine.The use of central nervous system active drugs during pregnancy.Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.Nongenetic risk factors and congenital heart defects.The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Prenatal exposure to antidepressants and risk of epilepsy in childhood.Maternal risk factors for gastroschisis in Canada.In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis.
P2860
Q26741187-13BEFAE4-412D-42F9-86B5-BDB94F3BE00CQ28077342-A5845EE0-03ED-4667-8307-FCBF3F0EFDAAQ30620024-CEA42381-AF38-4E1C-A0FA-085B392B68AEQ33910872-A689DEB4-659B-4565-B671-19DDE1DDAE00Q34068023-4B65F4D3-B778-407C-A923-AFEB2351DB01Q35078632-381FF5B9-A8EE-4096-930B-EB729080C220Q35541040-D744E9D0-2750-4734-B63B-ACFBF43B1D1DQ35957504-6A490C69-D762-42A0-93DF-8302C517E383Q36797574-E8973EAC-65B7-42D7-AEA4-95F33DDB654AQ37280003-4CA55BF6-F6FA-4731-AA57-DFFC679AE8D6Q37612128-017F0ED3-13ED-4F4C-9281-21D8F225B0D1Q38130429-10BF0E07-55B5-47D1-917D-0533675A9350Q38382317-A404E920-CA85-4B62-BAE6-1CF64EDF1731Q38811512-CD6AFF0A-1F78-4524-BE0C-95EC1947BCB6Q40498883-326573C7-AB46-4C46-B424-02DA8937C212Q41432014-6A0D3A51-FA03-440C-AFE0-2C8B1E491866Q50879823-71FD2372-E3D7-4170-88CF-6FBA486DB2F4Q55313592-6C079D5F-83BC-4AC7-B947-146B4FB65DF8
P2860
Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Association between reported v ...... s prevention study, 1997-2007.
@ast
Association between reported v ...... s prevention study, 1997-2007.
@en
type
label
Association between reported v ...... s prevention study, 1997-2007.
@ast
Association between reported v ...... s prevention study, 1997-2007.
@en
prefLabel
Association between reported v ...... s prevention study, 1997-2007.
@ast
Association between reported v ...... s prevention study, 1997-2007.
@en
P2860
P50
P356
P1476
Association between reported v ...... s prevention study, 1997-2007.
@en
P2093
Kara N D Polen
P2860
P356
10.1002/BDRA.23096
P577
2012-12-26T00:00:00Z